Comparative hemostatic parameters in BALB/c, C57BL/6 and C3H/He mice

Thrombosis Research

Volumn 124, Issue 3, 2009, Pages 338-343

  Barrios, Mariana ^a   Rodríguez Acosta, Alexis ^b   Gil, Amparo ^a   Salazar, Ana M ^a   Taylor, Peter ^a   Sánchez, Elda E ^c   Arocha Piñango, Carmen L ^a   Guerrero, Belsy ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c TEXAS A AND M UNIVERSITY KINGSVILLE   (United States)

Author keywords

BALB c; C3H He; C57BL 6; Hematological parameters; Hemostatic parameters; Mice

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRINOGEN; HEMOGLOBIN; PLASMINOGEN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EYE; FIBRINOLYSIS; HEART; HEMATOCRIT; HEMOSTASIS; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT;

ANIMALS; BLOOD COAGULATION FACTORS; HEMOSTASIS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; PLATELET COUNT; SPECIES SPECIFICITY;

EID: 67649697701     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.11.001     Document Type: Article

References (47)

1. Tsakiris D.A., Scudder L., Hodivala-Dilke K., Hynes R., and Coller B. Hemostasis in the mouse (Mus musculus): A review. Thromb Haemost 81 (1999) 177-188
2. Hogan K.A., Harmut W., and Lord S. Mouse models in coagulation. Thromb Haemost 87 (2002) 563-574
3. Cubillos S., Scallon B., Feldmann M., and Taylor P. Effect of blocking TNF on IL-6 levels and metastasis in a B16-BL6 melanoma/mouse model. Anticancer Res 17 (1997) 2207-2212
4. Lomonte B., Tarkowski A., and Hanson L. Host response to Bothrops asper snake venom: analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation 17 (1993) 93-105
5. Denis C., Methia N., Frenette P.S., Rayburn H., Ullman-Culleré M., Hynes R.O., et al. Mouse model of severe von Willerbrand disease: defects in hemostasis and thrombosis. Proc Nat Acad Sci 95 (1998) 9524-29
6. Frith C.H., Suber R., and Umholtz R. Hematologic and clinical chemistry findings in control BALB/c and C57BL/6 mice. Lab Anim Sci 30 (1980) 835-840
7. Schaneck K., Washington M., Holder D., Lodge K., and Motzel S. Hematologic and serum biochemical reference values in nontransgenic FVB mice. Comp Med 50 (2000) 32-35
8. Nemzek J.A., Bolgos G.L., Williams B.A., and Remick D.G. Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling site. Inflamm Res 50 (2001) 523-527
9. Peters L., Cheever E., Ellis H., Magnani P., Svenson K., von Smith R., et al. Large-scale, high-throughput screening for coagulation and hematologic phenotypes in mice. Physiol Genomics 11 (2002) 185-193
10. Schenell M.A., Hardy C., Hawley M., Propert K., and Wilson J. Effect of blood collection technique in mice on clinical pathology parameters. Hum Gen Ther 13 (2002) 155-162
11. Voronov E., Apte R.N., and Sofer S. The systemic inflammatory response syndrome related to the release of cytokines following severe envenomation. J Venom Anim Toxins 5 (1999) 1-29
12. Browder T., Folkman J., and Pirie-Shepherd S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 275 (2000) 1521-1524
13. Cirino G., Napoli C., Bucci M., and Cicala C. Inflammation-coagulation network: are serine protease receptors the knot?. Trends Pharmacol Sci 21 (2000) 170-172
14. Rickles F.R., and Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 102 (2001) V215-V224
15. Dellinger R.P. Inflammation and coagulation: implications for the septic patient. Clin Infect Dis 36 (2003) 1259-1265
16. Colman R.W., Clowes A.W., George J.N., Goldhaber S.Z., and Marder V.J. Overview of hemostasis. In: Colman R.W., Marder V.J., Clowes A.W., George J.N., and Goldhaber S.Z. (Eds). Hemostasis and Thrombosis: Basic Principles and Clinical Practice (2006), Lippincott Williams & Wilkins, London 1-16
17. Dardik R., Loscalzo J., and Inbal A. Factor XIII (FXIII) and angiogenesis. J Thromb Haemost 4 (2006) 19-25
18. Medcalf R.L. Fibrinolysis, inflammation, and regulation of the plasminogen activating system. J Thromb Haemost 1 (2007) 132-142
19. Otero R., Osorio G., Valderrama R., and Giraldo A. Pharmacologic and enzymatic effects of snake venoms from Antioquia and Chocó (Colombia). Toxicon 30 (1992) 611-620
20. Gutierrez J.M., Romero M., Diaz C., Borkow G., and Ovadia M. Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon 33 (1995) 19-29
21. Saravia P., Rojas E., Arce V., Guevara C., Lopez J.C., Chaves E., et al. Geographic and ontogenic variability in the venom of the Neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications. Rev Biol Trop 50 (2002) 337-346
22. Anonymous. Principles of laboratory animal care (1985), National Institute of Health, USA Pub. 85 N° 23
23. Giles A. Guidelines for the use of animals in biomedical research. Thromb Haemost 58 (1987) 1078-1084
24. Van Kampen E.J., and Zijlstra W.G. Determination of hemoglobin and its derivatives. Adv Clin Chem 8 (1965) 141-187
25. Brecher G., and Cronkite E.P. Morphology and enumeration of human blood platelets. J Appl Physiol 3 (1950) 365-377
26. Ingram G.I.C. The determination of plasma fibrinogen by the clot-weight method. Biochem J 51 (1952) 583-585
27. Coggan M., and Board P.G. A fluorescent spot test for coagulation factor XIII. Ann Biochem 137 (1984) 402-404
28. Mussoni L., Raczka E., Chmielewska J., Donati M.B., and Lattalo Z.S. Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate S-2251. Thromb Res 15 (1979) 341-349
29. Marsh N.A., and Arocha-Piñango C.L. Evaluation of the fibrin plate method for estimating plasminogen activators. Thromb Diath Haemorrh 28 (1972) 75-88
30. Lago O., Szwarcer E., and Pizzutto J. Tiempo de lisis de euglobulinas. In: Kordich L., Sánchez J., Vidal H., and De Campos C. (Eds). Manual de Hemostasia y Trombosis. Grupo Cooperativo de Hemostasia y Trombosis (1991), Imprenta de la Federación Bioquímica de la Provincia de Buenos Aires, Argentina 367-370
31. NIST/SEMATECH. e-Handbook of Statistical Methods, http://www.itl.nist.gov/ div898/handbook/, date. (2008).
32. Hoover-Plow J., Shchurin A., Hart E., Sha J., Hill A.E., Singer J.B., et al. Genetic background determines response to hemostasis and thrombosis. BMC Blood Disord 6 (2006) 6 10.1186/1471-2326-6-6
33. Festing M.F.W., Diamanti P., and Turton J.A. Strain differences in haematological response to chloramphenicol succinate in mice: implications for toxicological research. Food Chem Toxicol 39 (2001) 375-383
34. Tsai P.P., Pachowsky U., Stelzer H.D., and Hackbarth H. Impact of environmental enrichment in mice. 1: Effect of housing conditions on body weight, organ weights and haematology in different strains Laboratory Animals Ltd. Lab Anim 36 (2002) 411-419
35. Plopis V.A., Carmeliet P., Vazirzadeh S., Van Vlaenderen I., Moons L., Plow E., et al. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 92 (1995) 2585-2593
36. Laurer P., Metzner H.J., Zettlmeibi G., Li M., Smith A.G., Lathe R., et al. Targeted inactivation of the mouse locus encoding coagulation Factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost 88 (2002) 967-974
37. Mackman N. Mouse models in hemostasis and thrombosis. Thromb Haemost 92 (2004) 440-443
38. Matsuo O, Lijnen HR, Ueshima S, Kojima S, and Smyth SSA guide to murine fibrinolytic factor structure, function, assays, and genetic alterations. J Thromb Haemost 5 (2007) 680-689
39. Lorand L. Factor XIII and the clotting of fibrinogen: from basic research to medicine. J Thromb Haemost 3 (2005) 1337-1348
40. Booth N.A., and Bachmann F. Plasminogen-Plasmin System. In: Colman R.W., Marder V.J., Clowes A.W., George J.N., and Goldhaber S.Z. (Eds). Hemostasis and Thrombosis: Basic Principles and Clinical Practice (2006), Lippincott Williams & Wilkins, London 276-320
41. Lijnen H.R., van Hoef B., Beelen V., and Collen D. Characterization of the murine plasma fibrinolytic system. Eur J Biochem 224 (1994) 863-871
42. Lijnen H.R., Van Hoef B., and Collen D. Characterization of the murine plasminogen/urokinase-type plasminogen-activator system. Eur J Biochem 241 (1996) 840-848
43. Marval E., Guerrero B., and Arocha-Piñango C.L. The action of Lonomia achelous caterpillar venom on some blood coagulation and fibrinolysis parameters of the rabbit. Toxicon 37 (1999) 1491-1504
44. Tambourgi D.V., Petricevich V.L., Magnoli F.C., Assaf S.L., Jancar S., and Dias Da Silva W. Endotoxemic-like shock induced by Loxosceles spider venoms: pathological chances and putative cytokine mediators. Toxicon 36 (1998) 391-403
45. Petricevich V.L., and Peña C.F. The dynamics of cytokines and nitric oxide secretion in mice injected with Tityus serrulatus scorpion venom. Mediat Inflamm 11 (2002) 173-180
46. Barros S.F., Friedlanskaia I., Petricevich V.L., and Kipnis T.L. Local inflammation, lethality and cytokine release in mice injected with Bothrops atrox venom. Mediat Inflamm 7 (1998) 339-346
47. D'Império-Lima M.R., Santos M.C., Tambourgi D.V., Marques T., Dias da Silva W., and Kipnis T.L. Susceptibility of different strains of mice to South American rattle snake (Crotalus durissus durissus) venom: correlation between lethal effect and creatine kinase release. Toxicon 29 (1991) 783-786